Compounding of Veterinary Drugs for Equine Practitioners.
Equine practitioners should follow these recommendations when using compounded medications: (1) the decision must be veterinary driven, based on a valid veterinarian-client-patient relationship and on evidence-based medicine; (2) compliance with the Animal Medicinal Drug Use Clarification Act of 1994; and (3) use limited to (a) horses for which no other method or route of drug delivery is practical; (b) those drugs for which safety, efficacy, and stability have been demonstrated; or (c) disease conditions for which a quantifiable response to therapy or drug concentration can be monitored.
K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, 620 West Health Science Drive, Davis, CA 95616, USA. Electronic address: sdstanley@ucdavis.edu.
Scott D
SD
Stanley
K.L. Maddy Equine Analytical Chemistry Laboratory, School of Veterinary Medicine, University of California, Davis, 620 West Health Science Drive, Davis, CA 95616, USA.
Krysta
K
Moffitt
Director of Pharmacy, Adjunct Professor of the Department of Medicine and Epidemiology, William R. Prichard Veterinary Medical Teaching Hospital, University of California, Davis, Davis, CA, USA.
Valerie
V
Wiebe
D000818:Animals; D004339:Drug Compounding / Q000662:veterinary*; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D018634:Veterinarians; D019155:Veterinary Drugs / Q000008:administration & dosage* / Q000737:chemistry*
D019155:Veterinary Drugs
Compounding; Drugs; Extralabel drug use; Horses